04-1676 Sigma-AldrichGoat Anti-Mouse IgG Fab Antibody, clone RMG05
This goat monoclonal Goat Anti-Mouse IgG Fab, clone RMG05, Cat. No. 04-1676 is validated for use in ELISA, for the detection of Mouse IgG Fab.
More>> This goat monoclonal Goat Anti-Mouse IgG Fab, clone RMG05, Cat. No. 04-1676 is validated for use in ELISA, for the detection of Mouse IgG Fab. Less<<Produits recommandés
Aperçu
| Replacement Information |
|---|
Tableau de caractéristiques principal
| Species Reactivity | Key Applications | Host | Format | Antibody Type |
|---|---|---|---|---|
| M | ELISA | Gt | Purified | Monoclonal Antibody |
| Description | |
|---|---|
| Catalogue Number | 04-1676 |
| Description | Goat Anti-Mouse IgG Fab Antibody, clone RMG05 |
| References |
|---|
| Product Information | |
|---|---|
| Format | Purified |
| Presentation | Goat monoclonal in PBS with 1% BSA and 0.09% sodium azide. |
| Quality Segment | MQ300 |
| Applications | |
|---|---|
| Application | This goat monoclonal Goat Anti-Mouse IgG Fab, clone RMG05, Cat. No. 04-1676 is validated for use in ELISA, for the detection of Mouse IgG Fab. |
| Key Applications |
|
| Physicochemical Information |
|---|
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Packaging Information | |
|---|---|
| Material Size | 100 μg |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade ITEM Number | |
|---|---|
| Référence | GTIN |
| 04-1676 | 04055977181364 |
Documentation
Goat Anti-Mouse IgG Fab Antibody, clone RMG05 FDS
| Titre |
|---|
Goat Anti-Mouse IgG Fab Antibody, clone RMG05 Certificats d'analyse
| Titre | Numéro de lot |
|---|---|
| Goat Anti-Mouse IgG Fab, -QVP1504144 | QVP1504144 |
| Goat Anti-Mouse IgG Fab, clone RMG05 - VP1908020 | VP1908020 |
Informations techniques
| Titre |
|---|
| Characterization of Estrogen Receptor α Phosphorylation Sites in Breast Cancer Tissue Using the SNAP i.d® 2.0 System |
| White Paper: Further considerations of antibody validation and usage. |



